SynCore Biotechnology Co.,Ltd (4192.TWO)
TWD 27.05
(0.0%)
TWD 27.05
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 21.22 Million TWD | -88.69% |
| 2022 | 187.63 Million TWD | -50.82% |
| 2021 | 381.51 Million TWD | 7.95% |
| 2020 | 353.41 Million TWD | 132.75% |
| 2019 | 151.84 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 22.05 Million TWD | -17.99% |
| 2024 Q1 | 26.89 Million TWD | 26.72% |
| 2023 Q4 | 21.22 Million TWD | -81.04% |
| 2023 FY | 21.22 Million TWD | -88.69% |
| 2023 Q3 | 111.97 Million TWD | -37.04% |
| 2023 Q2 | 177.85 Million TWD | -0.72% |
| 2023 Q1 | 179.13 Million TWD | -4.53% |
| 2022 FY | 187.63 Million TWD | -50.82% |
| 2022 Q4 | 187.63 Million TWD | 0.0% |
| 2021 FY | 381.51 Million TWD | 7.95% |
| 2020 FY | 353.41 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 96.362% |
| Level Biotechnology Inc. | 273.2 Million TWD | 92.231% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 84.599% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 89.251% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 98.401% |
| GlycoNex Incorporation | 276.39 Million TWD | 92.321% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 93.234% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 95.876% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 94.237% |
| Visgeneer Inc. | 185.6 Million TWD | 88.564% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 98.396% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 97.104% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 82.291% |
| Neith Corporation | 17.43 Million TWD | -21.758% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 99.055% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -220.731% |
| Enimmune corporation | 173.46 Million TWD | 87.763% |
| TaiRx, Inc. | 60.62 Million TWD | 64.988% |
| EirGenix Inc. | 1.14 Billion TWD | 98.146% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 81.045% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 95.858% |
| Lin BioScience, Inc. | 167.73 Million TWD | 87.345% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 77.35% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | 66.326% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 82.982% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 86.821% |
| RBC Bioscience Corporation | 513.08 Million TWD | 95.863% |
| BiOptic Inc. | 170.56 Million TWD | 87.555% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | 49.651% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | 8.725% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | 20.837% |
| VBI | 21.25 Million TWD | 0.118% |
| CHO Pharma, Inc. | 110.83 Million TWD | 80.848% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -203.489% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 97.822% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -166.257% |
| NaviFUS Corp. | 53.4 Million TWD | 60.252% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 95.592% |
| Sinew Pharma Inc. | 39.71 Million TWD | 46.553% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | 63.428% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 94.176% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 90.678% |
| AP Biosciences Inc | 106.65 Million TWD | 80.098% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 99.399% |
| 3D Global Biotech Inc. | 30.68 Million TWD | 30.817% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 89.17% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 98.625% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 97.55% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -128.827% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | 61.969% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 90.889% |
| TCI GENE Inc. | 155.54 Million TWD | 86.354% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | 16.787% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | 54.031% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 93.538% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 67.288% |
| PharmaEngine, Inc. | 91 Million TWD | 76.676% |
| Savior Lifetec Corporation | 457.95 Million TWD | 95.365% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 80.867% |
| OBI Pharma, Inc. | 650.44 Million TWD | 96.737% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 94.569% |
| Acepodia, Inc. | 384.47 Million TWD | 94.479% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 75.19% |